News | June 23, 2015

Accuray Initiates International Commercial Launch of the InCise Multileaf Collimator

Add-on to robotic CyberKnife M6 System launched following evaluation in the Netherlands

Accuray, CyberKnife M6, InCise MLC, collimator, international launch

Image courtesy of Accuray Inc.

June 23, 2015 - Accuray Inc. announced in April that the InCise Multileaf Collimator (MLC) for the CyberKnife M6 System is available outside the United States in markets where it is approved for sale. The InCise MLC was launched in the U.S. market in February.

The launch follows the successful completion of the evaluation of the InCise MLC by Erasmus MC Cancer Institute in Rotterdam, the Netherlands, the European evaluation site working in collaboration with Accuray. Two sites in the U.S. had previously completed their successful evaluation of the InCise MLC. The main benefits of the MLC reported by the sites were the ability to treat a broader range of tumors than they could with fixed collimators or the Iris Collimator, and to do so with significantly increased efficiency. The InCise MLC was featured at the European Society for Therapeutic Radiology and Oncology (ESTRO) meeting in Barcelona, Spain, April 24 – 27.

The InCise MLC is one of the world's first multileaf collimators to be available on a robotic platform, the CyberKnife M6 System. The system's robotic design enables physicians to find the best angles for radiation to enter and exit the body, thus maximizing dose to the target while minimizing exposure to healthy tissue. The robotic design also enables the system to adjust and automatically stay on target in real-time, accounting for patient and tumor motion.

The CyberKnife M6 System can be used to treat tumors anywhere in the body, including the prostate, lung, brain, spine, liver, pancreas and kidney, and may offer hope to patients who have inoperable or surgically complex tumors, or who may prefer a clinically effective, non-surgical option.

For more information: www.accuray.com

Related Content

New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core

The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core. Credit: Wenpei Fan, LOMIN Laboratory, NIBIB.

News | Radiation Therapy | May 08, 2019
Radiation kills tumors by creating oxygen free radicals that damage the tumor DNA. However, the lack of oxygen in the...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018.

Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018. 

Feature | May 01, 2019
May 1, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine webs
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
Researchers Identify Ways to Predict and Avoid Radiotherapy Side Effects
News | Radiation Therapy | April 30, 2019
New research has shown a combination of biological markers and certain genetic changes can predict radiation...